Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on May 31, 2021 11:31am
105 Views
Post# 33296214

RE:RE:RE:RE:RE:THTX Weekly Report Card

RE:RE:RE:RE:RE:THTX Weekly Report CardYou are right that revenge is not in my vocabularly but I have not even made it to stage five yet - acceptance!

I believe the weekly approach is best for these Report Cards. There are so many issues TH could be addressing on the capital markets front that there shold be measurable weekly progress and we should be monitoring that and highlighting when they are not making enough progress. And we are not grading on a curve either. Sometimes tough love is what is required.

palinc2000 wrote: I think Spceo is trying hard to re ignite the stock price but the sense of urgency to adress the capital markets failings by management has somewhat lessened after All directors were re elected.
 Any one who has seen the movie Cruella which came out last week would know that the 6th stage of Grief is REVENGE ..... That word is not in Spceo s vocabulary !!!!!
I hope that a new Director is appointed  as promised soon but Unfortunately the process has been slowed..... I hope the new appointee coincides with the resignation of a current director




<< Previous
Bullboard Posts
Next >>